Advent Venture Partners Llp - Net Worth and Insider Trading
Advent Venture Partners Llp Net Worth
The estimated net worth of Advent Venture Partners Llp is at least $3 Million dollars as of 2024-11-07. Advent Venture Partners Llp is the 10% Owner of Conatus Pharmaceuticals Inc and owns about 6,031,709 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $3 Million. Details can be seen in Advent Venture Partners Llp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advent Venture Partners Llp has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Advent Venture Partners Llp
Advent Venture Partners Llp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Advent Venture Partners Llp owns 1 companies in total, including Histogen Inc (HSTO) .
Click here to see the complete history of Advent Venture Partners Llp’s form 4 insider trades.
Insider Ownership Summary of Advent Venture Partners Llp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTO | Histogen Inc | 2013-07-24 | 10 percent owner |
Advent Venture Partners Llp Latest Holdings Summary
Advent Venture Partners Llp currently owns a total of 1 stock. Advent Venture Partners Llp owns 6,031,709 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $3 Million.
Latest Holdings of Advent Venture Partners Llp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 6,031,709 | 0.56 | 3,377,757 |
Holding Weightings of Advent Venture Partners Llp
Advent Venture Partners Llp Form 4 Trading Tracker
According to the SEC Form 4 filings, Advent Venture Partners Llp has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 535 shares on July 30, 2013, which brought Advent Venture Partners Llp around $5,885.
Insider Trading History of Advent Venture Partners Llp
- 1
Advent Venture Partners Llp Trading Performance
Advent Venture Partners Llp Ownership Network
Ownership Network List of Advent Venture Partners Llp
Ownership Network Relation of Advent Venture Partners Llp
Advent Venture Partners Llp Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Advent Venture Partners Llp is the 10 percent owner of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Advent Venture Partners Llp Mailing Address
Above is the net worth, insider trading, and ownership report for Advent Venture Partners Llp. You might contact Advent Venture Partners Llp via mailing address: 25 Buckingham Gate, London A1 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
